The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Quinolone-Mediated Bacterial Death
Open accessAbstract
The fluoroquinolones are broad-spectrum antibacterial agents that are becoming increasingly popular as bacterial resistance erodes the effectiveness of other agents (fluoroquinolone sales accounted for 18% of the antibacterial market in 2006) (41). One of the attractive features of the quinolones is their ability to kill bacteria rapidly, an ability that differs widely among the various derivatives. For example, quinolones differ in rate and extent of killing, in the need for aerobic metabolism to kill cells, and in the effect of protein synthesis inhibitors on quinolone lethality. Understanding the mechanisms underlying these differences could lead to new ways for identifying the most bactericidal quinolone derivatives. Before describing the types of damage caused by the quinolones, it is useful to define lethal activity. Operationally, it is the ability of drug treatment to reduce the number of viable cells, usually measured as CFU on drug-free agar after treatment. This assay is distinct from measurements that detect inhibition of growth (e.g., MIC), since with the latter bacteria are exposed to drug throughout the measurement. The distinction between killing and blocking growth is important because it allows susceptibility determinations to be related to particular biological processes. For example, inhibition of growth is typically reversed by the removal of drug, while cell death is not. Thus, biochemical events associated with blocking growth should be readily reversible, while those responsible for cell death should be difficult to reverse. Reversibility can be used to distinguish among quinolone derivatives and assign functions to particular aspects of drug structure. Moreover, protective functions, such as repair and stress responses, can be distinguished by whether their absence affects inhibition of growth, killing, or both. The intracellular targets of the quinolones are two DNA topoisomerases: gyrase and topoisomerase IV. Gyrase tends to be the primary target in gram-negative bacteria, while topoisomerase IV is preferentially inhibited by most quinolones in gram-positive organisms (28). Both enzymes use a double-strand DNA passage mechanism, and it is likely that quinolone biochemistry is similar for both. However, physiological differences between the enzymes exist, some of which may bear on quinolone lethality. In the present minireview we consider cell death through a two-part “poison” hypothesis in which the quinolones form reversible drug-topoisomerase-DNA complexes that subsequently lead to several types of irreversible (lethal) damage. Other consequences of quinolone treatment, such as depletion of gyrase and topoisomerase IV activity, are probably less immediate (42). To provide a framework for considering quinolone lethality, we begin by briefly describing the drug-topoisomerase-DNA complexes. Readers interested in a more comprehensive discussion of quinolones are referred to a previously published work (28).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Prokaryotic toxin–antitoxin stress response loci
Gerdes, K., Christensen, S. K., & Løbner-Olesen, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1147 · Cited by 1,033
Hsiang, Y. H., Lihou, M. G., & Liu, L. F. (1989) · PubMed · Cited by 1,028
Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity
Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T., & Tomizawa, J.-I. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4772 · Cited by 833
Sugino, A., Peebles, C. L., Kreuzer, K. N., & Cozzarelli, N. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4767 · Cited by 784
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
On the structure of the folded chromosome of Escherichia coli
Worcel, A., & Burgi, E. (1972) · Journal of Molecular Biology · doi:10.1016/0022-2836(72)90342-7 · Cited by 643
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 570
Crystal structure of the breakage–reunion domain of DNA gyrase
Cabral, J. H. M., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A., & Liddington, R. C. (1997) · Nature · doi:10.1038/42294 · Cited by 456
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Kreuzer, K. N., & Cozzarelli, N. R. (1979) · Journal of Bacteriology · doi:10.1128/jb.140.2.424-435.1979 · Cited by 337
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli
Yamagishi, J.-I., Yoshida, H., Yamayoshi, M., & Nakamura, S. (1986) · Molecular and General Genetics MGG · doi:10.1007/bf00331012 · Cited by 263
Escherichia coli mazEF -Mediated Cell Death Is Triggered by Various Stressful Conditions
Hazan, R., Sat, B., & Engelberg-Kulka, H. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.11.3663-3669.2004 · Cited by 254
DNA gyrase action involves the introduction of transient double-strand breaks into DNA.
Mizuuchi, K., Fisher, L. M., O'Dea, M. H., & Gellert, M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.4.1847 · Cited by 247
Programmed Cell Death in Escherichia coli : Some Antibiotics Can Trigger mazEF Lethality
Sat, B., Hazan, R., Fisher, T., Khaner, H., Glaser, G., & Engelberg-Kulka, H. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.6.2041-2045.2001 · Cited by 228
Mechanism of quinolone inhibition of DNA gyrase
Shen, L. L., Kohlbrenner, W. E., Weigl, D., & Baranowski, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81708-8 · Cited by 214
DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
Zhao, X., Xu, C., Domagala, J., & Drlica, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13991 · Cited by 213
Self-citationTsao, Y., Russo, A. A., Nyamuswa, G., SILBER, R. H., & Liu, L. F. (1993) · PubMed · Cited by 206
DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid
Snyder, M., & Drlica, K. (1979) · Journal of Molecular Biology · doi:10.1016/0022-2836(79)90077-9 · Cited by 203
Self-citationNalidixic Acid: an Antibacterial Paradox
Crumplin, G. C., & Smith, J. T. (1975) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.8.3.251 · Cited by 194
Lex marks the spot: the virulent side of SOS and a closer look at the LexA regulon
Kelley, W. L. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05444.x · Cited by 177
mazEF: a chromosomal toxin-antitoxin module that triggers programmed cell death in bacteria
Engelberg-Kulka, H., Hazan, R., & Amitai, S. (2005) · Journal of Cell Science · doi:10.1242/jcs.02619 · Cited by 165
The Mechanism of Inhibition of Topoisomerase IV by Quinolone Antibacterials
Khodursky, A. B., & Cozzarelli, N. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27668 · Cited by 163
Barnard, F. M., & Maxwell, A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.1994-2000.2001 · Cited by 160
Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands.
Berger, J. M., Fass, D., & Bogden, C. E. (1999) · Nature Structural Biology · doi:10.1038/7556 · Cited by 151
Organization of supercoil domains and their reorganization by transcription
Deng, S. H., Stein, R. A., & Higgins, N. P. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04796.x · Cited by 138
Willmott, C., Critchlow, S. E., Eperon, I. C., & Maxwell, A. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1586 · Cited by 136
Hiasa, H., Yousef, D. O., & Marians, K. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26424 · Cited by 136
Quinolone-Binding Pocket of DNA Gyrase: Role of GyrB
Heddle, J. G., & Maxwell, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1805-1815.2002 · Cited by 125
Fournier, B., Zhao, X., Lu, T., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2160-2165.2000 · Cited by 112
Self-citationWolfson, J. S., Hooper, D. C., McHugh, G., Bozza, M. A., & Swartz, M. N. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.1938 · Cited by 110
Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin
Diver, J. M., & Wise, R. A. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.supplement_d.31 · Cited by 91
Kolodkin‐Gal, I., & Engelberg–Kulka, H. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.9.3420-3423.2006 · Cited by 90
DNA Cleavage Is Not Required for the Binding of Quinolone Drugs to the DNA Gyrase−DNA Complex
Critchlow, S. E., & Maxwell, A. (1996) · Biochemistry · doi:10.1021/bi9603175 · Cited by 89
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene
Kumagai, Y., Kato, J., Hoshino, K., Akasaka, T., Sato, K., & Ikeda, H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.710 · Cited by 88
4-Quinolones and the SOS response
Lewin, C. S., Howard, B. M. A., Ratcliff, N. T., & Smith, J. T. (1989) · Journal of Medical Microbiology · doi:10.1099/00222615-29-2-139 · Cited by 87
The Interaction of Drugs with DNA Gyrase: A Model for the Molecular Basis of Quinolone Action
Heddle, J. G., Barnard, F. M., Wentzell, L. M., & Maxwell, A. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033048 · Cited by 83
Wentzell, L. M., & Maxwell, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4266 · Cited by 83
Pohlhaus, J. R., & Kreuzer, K. N. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04638.x · Cited by 80
Role of Escherichia coli RecBC enzyme in SOS induction
Chaudhury, A. M., & Smith, G. R. (1985) · Molecular and General Genetics MGG · doi:10.1007/bf00331350 · Cited by 80
Piddock, L. J. V., Walters, R. N., & Diver, J. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2331 · Cited by 78
Piddock, L. J. V., & Walters, R. N. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.819 · Cited by 62
Reversibility of SOS-associated division inhibition in Escherichia coli
Maguin, E., Lutkenhaus, J., & D’Ari, R. (1986) · Journal of Bacteriology · doi:10.1128/jb.166.3.733-738.1986 · Cited by 60
Quinolones Inhibit DNA Religation Mediated by Staphylococcus aureus Topoisomerase IV
Anderson, V. E., Zaniewski, R. P., Kaczmarek, F. S., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35927 · Cited by 51
Noble, C. G., Barnard, F. M., & Maxwell, A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.854-862.2003 · Cited by 40
Illegitimate recombination mediated by double-strand break and end-joining in
IKEDA, H., SHIRAISHI, K., & Ogata, Y. (2004) · Advances in Biophysics · doi:10.1016/s0065-227x(04)80031-5 · Cited by 40
Lewin, C. S., Howard, B. M. A., & Smith, J. T. (1991) · Journal of Medical Microbiology · doi:10.1099/00222615-34-1-19 · Cited by 37
Malik, M., & Drlica, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00250-06 · Cited by 37
Self-citationHiasa, H. (2002) · Biochemistry · doi:10.1021/bi026352v · Cited by 36
Illegitimate recombination mediated by double-strand break and end-joining in Escherichia coli.
Ikeda, H., Shiraishi, K., & Ogata, Y. (2004) · PubMed · Cited by 35
Hong, G., & Kreuzer, K. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0835166100 · Cited by 34
Function of the SOS Process in Repair of DNA Damage Induced by Modern 4-Quinolones
Howard, B. M. A., Pinney, R. J., & Smith, J. T. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb05673.x · Cited by 33
Malik, M., Lu, T., Zhao, X., Singh, A., Hattan, C. M., Domagala, J. M., Kerns, R. J., & Drlica, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2008-2014.2005 · Cited by 31
Self-citationDistinct Effects of the UvrD Helicase on Topoisomerase- Quinolone-DNA Ternary Complexes
Shea, M. E., & Hiasa, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14649 · Cited by 27
Asami, Y., Jia, D.-W., Tatebayashi, K., Yamagata, K., Tanokura, M., & Ikeda, H. (2002) · Gene · doi:10.1016/s0378-1119(02)00622-4 · Cited by 17
The RuvAB Branch Migration Complex Can Displace Topoisomerase IV·Quinolone·DNA Ternary Complexes
Shea, M. E., & Hiasa, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304217200 · Cited by 13
Cited by
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Self-citationFluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success
Redgrave, L. S., Sutton, S. B., Webber, M. A., & Piddock, L. J. V. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.04.007 · Cited by 1,008
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
Metadata
- Authors
- Drlica, K., Malik, M., Kerns, R. J., & Zhao, X.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-02
- Volume
- 52
- Issue
- 2
- Pages
- 385-392
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2007464877
- Cited by
- 570
- References
- 56
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.